New IR devices cleared by FDA | IR systems subject of recall | AI helps with interventional billing | 'Major shifts' in workload

One regulatory approval targets whole-body PET imaging analysis, while the other was designed to improve interventional workflows.

Both recalls are categorized as Class 2, which the FDA designates for issues that have the potential to “cause temporary or medically reversible adverse health consequences."

Translating procedures into standardized billing codes can be an arduous task, but researchers believe large language models offer an opportunity to simplify this work. 

The goal was to turn imaging surveillance into a routine part of post-surgical care, rather than an optional step.

“Understanding how these national patterns manifest within radiology departments is critical for optimizing staffing, credentialing, and quality improvement initiatives,” authors of a new analysis in Academic Radiology contend.

The safety notice was issued due to the risk of pieces of the needles dislodging into tissue during procedures. 

Often integrated with artificial intelligence, these systems have been shown to improve accuracy and reproducibility during IR care. 

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

Leaders at Philips are optimistic about how the new agreement could further advance its capabilities in image-guided coronary interventions.